European Journal of Cancer
Volume 39, Issue 17 , Page 2566 , November 2003

A comment on “Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders”

Received 5 June 2003 ,Accepted 13 June 2003.

References 

  1. Smeland S, Muller C, Alvegard TA, et al.  Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII (prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responder). Eur. J. Cancer. 2003;39:488–494
  2. Meyers PA, Heller G, Healey J, et al.  Chemotherapy for nonmetastatic osteogenic sarcoma (the Memorial Sloan Kettering experience). J. Clin. Oncol. 1992;10:5–15

☆ European Journal of Cancer 2003, 39, 488–494. Doi of article referred to: 10.1016/S0959-8049(02)00747-5.

PII: S0959-8049(03)00546-X

doi: 10.1016/S0959-8049(03)00546-X

European Journal of Cancer
Volume 39, Issue 17 , Page 2566 , November 2003

Article Tools